Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
Chief Science Officer
-
Issuer Symbol
-
NVCR on Nasdaq
There are no Buy or Sell transactions made by Moshe Giladi since 27 Jan 2025
Holdings reported by Moshe Giladi for NovoCure Ltd
| Security |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| Stock Options (Right to buy) |
78,174 |
$1,274,236 |
$16.30 |
27 Feb 2024 |
Direct |
Ordinary Shares |
|
| Ordinary Shares |
69,771 |
$1,137,267 |
$16.30 |
27 Feb 2024 |
Direct |
|
|
| Restricted Share Units |
353 |
|
|
26 Jul 2023 |
Direct |
|
|
Transactions reported by Moshe Giladi for NovoCure Ltd
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.